EVP, Chief Scientific Officer · Sana Biotechnology, Inc. · Common Stock
Side
M
Value
—
Shares
125.0K
Price
—
Executed
Aug 26, 2026
Disclosed
Aug 27, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Aug 26 executedAug 27, 2026 disclosed
SANA · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+13 / 25
No reported dollar value · 125.6% of prior position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Patel Dhavalkumar Dhirajlal filed this Form 4 reporting a option exercise of SANA on Aug 26, 2026. It became public on Aug 27, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
EVP, Chief Scientific Officer
Patel Dhavalkumar Dhirajlalcik:0002115339
Issuer
Sana Biotechnology, Inc.cik:0001770121
Revision history · 0
No field has changed since this record was first ingested.
SANASana Biotechnology, Inc.